C. Rouwé

发表

Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation

W. Kamps, A. Postma, A. Postma, 2005, Pediatric blood & cancer.

Family with autosomal dominant hyperinsulinism associated with A456V mutation in the glucokinase gene

R. Dullaart, K. Hoogenberg, C. Rouwé, 2004, Journal of internal medicine.

The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty

R. Odink, B. Otten, S. Drop, 1987, European Journal of Pediatrics.

Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.

T. Stijnen, B. Otten, W. H. Stokvis-Brantsma, 2003, The Journal of clinical endocrinology and metabolism.

Surgical Experience in Children With Differentiated Thyroid Carcinoma

J. Plukker, C. Rouwé, J. Haveman, 2003, Annals of Surgical Oncology.

Complex carbohydrates in the prevention of nocturnal hypoglycaemia in diabetic children.

C. Rouwé, M. Ververs, G. Smit, 1993, European journal of clinical nutrition.

17 b -Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations*

H. Kayserili, L. Sandkuijl, H. Delemarre-van de Waal, 1999 .

Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.

R. Hofstra, J. Plukker, J. D. de Groot, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Urinary steroid profile of a newborn suffering from pseudohypoaldosteronism.

J. C. van der Molen, C. Rouwé, G. Nagel, 1995, Clinica chimica acta; international journal of clinical chemistry.

Kinetics and metabolism of 11-deoxycortisol in a patient with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency

N. M. Drayer, C. Rouwé, G. Kraan, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

Total thyroidectomy in the treatment of thyroid carcinoma in childhood

A. Vermey, C. Rouwé, J. Plukker, 1995, The British journal of surgery.

Genotype versus phenotype in families with androgen insensitivity syndrome.

W J Kleijer, T. H. van der Kwast, H. Brunner, 2001, The Journal of clinical endocrinology and metabolism.

Final Height after Gonadotrophin Releasing Hormone Agonist Treatment for Central Precocious Puberty: The Dutch Experience

H. Delemarre-van de Waal, B. Otten, D. Mul, 2000, Journal of pediatric endocrinology & metabolism : JPEM.

Final height in central precocious puberty after long term treatment with a slow release GnRH agonist.

R. Odink, B. Otten, S. Drop, 1996, Archives of disease in childhood.

Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.

T. Stijnen, B. Otten, S. Drop, 1999, The Journal of clinical endocrinology and metabolism.

Postprandial Chylomicron Clearance Rate in Late Teenagers with Diabetes Mellitus Type 1

P. Sauer, R. Vonk, R. Odink, 2001, Pediatric Research.

Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.

T. Stijnen, H. Delemarre-van de Waal, J. Wit, 1996, The Journal of clinical endocrinology and metabolism.

Reduction of excessive height in boys by bilateral percutaneous epiphysiodesis around the knee

P. Sauer, R. Odink, C. Rouwé, 2005, European Journal of Pediatrics.

A new case of the osteodysplastic primordial dwarfism type II.

P. Willems, C. Rouwé, G. Smit, 1987, American journal of medical genetics.

Can GnRH Agonist Treatment Cause Slipped Capital Femoral Epiphysis?

C. Noordam, B. Otten, C. Rouwé, 2001, Journal of pediatric endocrinology & metabolism : JPEM.